Last10K.com

Neogenomics Inc (NEO) SEC Filing 8-K Material Event for the period ending Wednesday, April 29, 2020

Neogenomics Inc

CIK: 1077183 Ticker: NEO

View differences made from one to another to evaluate Neogenomics Inc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Neogenomics Inc.

Continue

Assess how Neogenomics Inc's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Neogenomics Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2020 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Financial Statements, Disclosures and Schedules

Inside this 8-K Corporate News

Ticker: NEO
CIK: 1077183
Form Type: 8-K Corporate News
Accession Number: 0001077183-20-000108
Submitted to the SEC: Mon May 04 2020 5:18:56 PM EST
Accepted by the SEC: Mon May 04 2020
Period: Wednesday, April 29, 2020
Industry: Testing Laboratories
Events:
  1. Ending Agreement
  2. Financial Exhibit
  3. New Agreement
  4. New Financial Obligation
  5. Other Events

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/neo/0001077183-20-000108.htm